| 中文名 | GSK-3抑制剂II |
|---|---|
| 英文名 | 2-[(3-iodophenyl)methylsulfanyl]-5-pyridin-4-yl-1,3,4-oxadiazole |
| 中文别名 |
GSK3Β 抑制剂II,10 MM DMSO 溶液
4-[5-[[(3-碘苯基)甲基]硫基]-1,3,4-恶二唑-2-基]吡啶 2-((3-碘苄基)硫基)-5-(吡啶-4-基)-1,3,4-恶二唑 GSK3Β 抑制剂II |
| 英文别名 |
2-THIO(3-IODOBENZYL)-5-(1-PYRIDYL)-[1,3,4]-OXADIAZOLE
GLYCOGEN SYNTHASE KINASE-3 INHIBITOR II GSK-3 INHIBITOR II GSK3β inhibitor II, 10 mM in DMSO GSK3.beta. Inhibitor II GSK-3β Inhibitor II - - Calbiochem 2-thio(3-iodobenzyl)-5-(1-pyridyl)-[1,3,4]oxadiazole 2-(3-iodobenzylthio)-5-(pyridin-4-yl)-1,3,4-oxadiazole Glycogen Synthase Kinase-3beta Inhibitor II TIBPO 4-[5-[[(3-Iodophenyl)methyl]thio]-1,3,4-oxadiazol-2-yl]pyridine 2-((3-Iodobenzyl)thio)-5-(pyridin-4-yl)-1,3,4-oxadiazole GSK-3 Inhibitor II GSK-3b Inhibitor II Pyridine, 4-[5-[[(3-iodophenyl)Methyl]thio]-1,3,4-oxadiazol-2-yl] GSK-3beta Inhibitor II HMS3229G14 GSK3β Inhibitor II |
| 描述 | GSK3β抑制剂II是一种GSK3α的抑制剂。GSK3β抑制剂II可用于阿尔茨海默病(AD)的研究[1]。 |
|---|---|
| 相关类别 | |
| 靶点 |
GSK-3β |
| 体外研究 | GSK3β抑制剂II与 Ile62、Phe67、Val70、Ala83和 亮氨酸188具有疏水相互作用,与 赖氨酸85具有离子相互作用,以及与 赖氨酸85和 阀门135残基具有氢键相互作用[1]。 GSK3β抑制剂II与 阀门135[1]形成氢键。 |
| 参考文献 |
| 分子式 | C14H10IN3OS |
|---|---|
| 分子量 | 395.21800 |
| 精确质量 | 394.95900 |
| PSA | 77.11000 |
| LogP | 4.02850 |
|
~%
478482-75-6 |
| 文献:Lo Monte, Fabio; Kramer, Thomas; Gu, Jiamin; Anumala, Upendra Rao; Marinelli, Luciana; La Pietra, Valeria; Novellino, Ettore; Franco, Benedicte; Demedts, David; Van Leuven, Fred; Fuertes, Ana; Dominguez, Juan Manuel; Plotkin, Batya; Eldar-Finkelman, Hagit; Schmidt, Boris Journal of Medicinal Chemistry, 2012 , vol. 55, # 9 p. 4407 - 4424 |
|
~%
478482-75-6 |
| 文献:Narum, Lars; Norskov-Lauritsen, Leif; Olesen, Preben H. Bioorganic and Medicinal Chemistry Letters, 2002 , vol. 12, # 11 p. 1525 - 1528 |
|
~%
478482-75-6 |
| 文献:Lo Monte, Fabio; Kramer, Thomas; Gu, Jiamin; Anumala, Upendra Rao; Marinelli, Luciana; La Pietra, Valeria; Novellino, Ettore; Franco, Benedicte; Demedts, David; Van Leuven, Fred; Fuertes, Ana; Dominguez, Juan Manuel; Plotkin, Batya; Eldar-Finkelman, Hagit; Schmidt, Boris Journal of Medicinal Chemistry, 2012 , vol. 55, # 9 p. 4407 - 4424 |
|
~%
478482-75-6 |
| 文献:Lo Monte, Fabio; Kramer, Thomas; Gu, Jiamin; Anumala, Upendra Rao; Marinelli, Luciana; La Pietra, Valeria; Novellino, Ettore; Franco, Benedicte; Demedts, David; Van Leuven, Fred; Fuertes, Ana; Dominguez, Juan Manuel; Plotkin, Batya; Eldar-Finkelman, Hagit; Schmidt, Boris Journal of Medicinal Chemistry, 2012 , vol. 55, # 9 p. 4407 - 4424 |
|
~%
478482-75-6 |
| 文献:Lo Monte, Fabio; Kramer, Thomas; Gu, Jiamin; Anumala, Upendra Rao; Marinelli, Luciana; La Pietra, Valeria; Novellino, Ettore; Franco, Benedicte; Demedts, David; Van Leuven, Fred; Fuertes, Ana; Dominguez, Juan Manuel; Plotkin, Batya; Eldar-Finkelman, Hagit; Schmidt, Boris Journal of Medicinal Chemistry, 2012 , vol. 55, # 9 p. 4407 - 4424 |
|
~%
478482-75-6 |
| 文献:Lukas, Thomas J.; Schiltz, Gary E.; Arrat, Hasan; Scheidt, Karl; Siddique, Teepu Bioorganic and Medicinal Chemistry Letters, 2014 , vol. 24, # 6 p. 1532 - 1537 |
| 上游产品 6 | |
|---|---|
| 下游产品 0 | |